Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ADA 2026 5 - 8 June 2026

Semaglutide and Obstructive Sleep Apnea (OSA): A Post Hoc Analysis From SELECT

Authors :

Silvio E. Inzucchi¹; Nina M. Harder-Lauridsen²; Søren Fjelstrup²; Ian J. Neeland³; Andrea Traina⁴; Lauren Wilson⁴; Donna H. Ryan⁵

Affiliations

View Details Hide Details

Download .PDF

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide (oral)

PHASE 3 (RCT)